BI 1034020 is a humanized nanobody, targeting two different epitopes of Abeta ( Abeta40 and Abeta42) with high affinity. BI 1034020 reduces the level of free Ab peptide in plasma and thus prevent the formation of new Abeta plaques and clear existing plaques. BI 1034020 can be used for Alzheimers disease research[1].
Target:
Amyloid-beta
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
